Carlos Franco-Muñoz

568 total citations
19 papers, 183 citations indexed

About

Carlos Franco-Muñoz is a scholar working on Infectious Diseases, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Carlos Franco-Muñoz has authored 19 papers receiving a total of 183 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 4 papers in Molecular Biology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Carlos Franco-Muñoz's work include SARS-CoV-2 and COVID-19 Research (14 papers), COVID-19 Clinical Research Studies (9 papers) and SARS-CoV-2 detection and testing (8 papers). Carlos Franco-Muñoz is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (14 papers), COVID-19 Clinical Research Studies (9 papers) and SARS-CoV-2 detection and testing (8 papers). Carlos Franco-Muñoz collaborates with scholars based in Colombia, United Kingdom and United States. Carlos Franco-Muñoz's co-authors include Marcela Mercado, Katherine Laiton‐Donato, Diego A. Álvarez-Díaz, Clemencia Ovalle‐Bracho, José A. Usme-Ciro, Martha Lucía Ospina Martínez, Juliana Barbosa-Ramírez, Lizdany Flórez‐Álvarez, Magdalena Wiesner and Marı́a Teresa Rugeles and has published in prestigious journals such as PLoS ONE, Emerging infectious diseases and Parasitology.

In The Last Decade

Carlos Franco-Muñoz

17 papers receiving 181 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlos Franco-Muñoz Colombia 8 121 42 32 32 16 19 183
Diego A. Álvarez-Díaz Colombia 9 140 1.2× 65 1.5× 28 0.9× 20 0.6× 14 0.9× 26 195
Cynthia Y. Tang United States 8 129 1.1× 29 0.7× 28 0.9× 50 1.6× 11 0.7× 23 223
Martha Lucía Ospina Martínez Colombia 7 140 1.2× 106 2.5× 16 0.5× 25 0.8× 12 0.8× 11 195
Xiangyanyu Xu China 5 119 1.0× 27 0.6× 47 1.5× 38 1.2× 10 0.6× 6 190
Hsin-Ping Chiu Taiwan 7 142 1.2× 40 1.0× 56 1.8× 61 1.9× 5 0.3× 7 279
Shijia Ge China 6 212 1.8× 19 0.5× 60 1.9× 39 1.2× 11 0.7× 11 251
Rebeca Santano Spain 6 105 0.9× 25 0.6× 32 1.0× 11 0.3× 18 1.1× 8 184
Elio Issa Lebanon 7 180 1.5× 45 1.1× 63 2.0× 39 1.2× 7 0.4× 9 283
Anderson Vicente de Paula Brazil 9 140 1.2× 42 1.0× 15 0.5× 37 1.2× 25 1.6× 19 189
Stephane Tosta Brazil 5 105 0.9× 14 0.3× 65 2.0× 17 0.5× 5 0.3× 8 146

Countries citing papers authored by Carlos Franco-Muñoz

Since Specialization
Citations

This map shows the geographic impact of Carlos Franco-Muñoz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Franco-Muñoz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Franco-Muñoz more than expected).

Fields of papers citing papers by Carlos Franco-Muñoz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Franco-Muñoz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Franco-Muñoz. The network helps show where Carlos Franco-Muñoz may publish in the future.

Co-authorship network of co-authors of Carlos Franco-Muñoz

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Franco-Muñoz. A scholar is included among the top collaborators of Carlos Franco-Muñoz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Franco-Muñoz. Carlos Franco-Muñoz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
3.
Laiton‐Donato, Katherine, et al.. (2022). Monkeypox virus genome sequence from an imported human case in Colombia. Biomédica. 42(3). 541–545. 6 indexed citations
4.
Álvarez-Díaz, Diego A., et al.. (2022). Clinical outcomes associated with Mu variant infection during the third epidemic peak of COVID-19 in Colombia. International Journal of Infectious Diseases. 125. 149–152. 1 indexed citations
6.
Álvarez-Díaz, Diego A., et al.. (2022). Low Neutralizing Antibody Titers against the Mu Variant of SARS-CoV-2 in 31 BNT162b2 Vaccinated Individuals in Colombia. Vaccines. 10(2). 180–180. 14 indexed citations
7.
Laiton‐Donato, Katherine, José A. Usme-Ciro, Carlos Franco-Muñoz, et al.. (2021). Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K. Frontiers in Medicine. 8. 697605–697605. 5 indexed citations
8.
Álvarez-Díaz, Diego A., et al.. (2021). Reduced levels of convalescent neutralizing antibodies against SARS-CoV-2 B.1+L249S+E484K lineage. Virus Research. 308. 198629–198629. 5 indexed citations
9.
Laiton‐Donato, Katherine, Christian Julián Villabona‐Arenas, José A. Usme-Ciro, et al.. (2020). Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2, Colombia. Emerging infectious diseases. 26(12). 2854–2862. 21 indexed citations
10.
Díaz, Francisco J., Wbeimar Aguilar-Jiménez, Lizdany Flórez‐Álvarez, et al.. (2020). Aislamiento y caracterización de una cepa temprana de SARS-CoV-2 durante la epidemia de 2020 en Medellín, Colombia. Biomédica. 40(Supl. 2). 148–158. 18 indexed citations
11.
Álvarez-Díaz, Diego A., Carlos Franco-Muñoz, Katherine Laiton‐Donato, et al.. (2020). Molecular analysis of several in-house rRT-PCR protocols for SARS-CoV-2 detection in the context of genetic variability of the virus in Colombia. Infection Genetics and Evolution. 84. 104390–104390. 37 indexed citations
12.
Álvarez-Díaz, Diego A., Katherine Laiton‐Donato, Carlos Franco-Muñoz, & Marcela Mercado. (2020). Secuenciación del SARS-CoV-2: la iniciativa tecnológica para fortalecer los sistemas de alerta temprana ante emergencias de salud pública en Latinoamérica y el Caribe. Biomédica. 40(Supl. 2). 188–197. 6 indexed citations
13.
Franco-Muñoz, Carlos, Diego A. Álvarez-Díaz, Katherine Laiton‐Donato, et al.. (2020). Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in South America. Infection Genetics and Evolution. 85. 104557–104557. 18 indexed citations
14.
Laiton‐Donato, Katherine, Christian Julián Villabona‐Arenas, José A. Usme-Ciro, et al.. (2020). Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2, Colombia. Emerging infectious diseases. 26(12). 2854–2862. 2 indexed citations
15.
Malagón-Rojas, Jeadran, et al.. (2020). SARS-CoV-2 y RT-PCR en pacientes asintomáticos: resultados de una cohorte de trabajadores del Aeropuerto Internacional El Dorado de Bogotá, 2020. Biomédica. 40(Supl. 2). 166–172. 7 indexed citations
16.
Lozano, José Manuel, Luz Mary Salazar, Ángela Torres, et al.. (2020). COVID-19 Infection Detection and Prevention by SARS-CoV-2 Active Antigens: A Synthetic Vaccine Approach. Vaccines. 8(4). 692–692. 3 indexed citations
17.
Franco-Muñoz, Carlos, et al.. (2018). Intraspecies differences in natural susceptibility to amphotericine B of clinical isolates of Leishmania subgenus Viannia. PLoS ONE. 13(4). e0196247–e0196247. 7 indexed citations
18.
Ovalle‐Bracho, Clemencia, et al.. (2015). Changes in Macrophage Gene Expression Associated with Leishmania (Viannia) braziliensis Infection. PLoS ONE. 10(6). e0128934–e0128934. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026